Applied Genetic Technologies Corporation

AGTC · NASDAQ
Analyze with AI
9/30/2022
6/30/2022
3/31/2022
12/31/2021
Operating Activities
Net Income-$18-$18-$14-$19
Dep. & Amort.$0$0$0$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$1$1$2
Change in WC$0-$1-$1-$0
Other Non-Cash-$0$0$0$17
Operating Cash Flow-$17-$18-$14$0
Investing Activities
PP&E Inv.-$0-$1-$0-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$0$0$0$2
Investing Cash Flow-$0-$1-$0$1
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0-$0$9$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$7-$2$0$0
Financing Cash Flow$7-$2$9$0
Forex Effect$1$0$0$0
Net Chg. in Cash-$9-$21-$5-$18
Supplemental Information
Beg. Cash$46$68$73$91
End Cash$37$46$68$73
Free Cash Flow-$18-$19-$14-$1